Trustmark

TRMK · NASDAQ

$45.40+$0.89 (+2.00%)TodayMarket closed · Oct 20, 4:10 PM ET

Prev close $44.51

TRMK analyst rating

HoldConsensus of 4 analysts over the last 12 months. 0% rate it a buy.

Strong buy0
Buy0
Hold4
Underperform0
Sell0

12-month price target · 7 analysts

Average $51.00 (+12.3% upside)

Low: $46.97
Now: $45.40
High: $58.27

Upgrades and downgrades

The latest rating actions, newest first

TRMK analyst upgrades, downgrades and rating actions
Firm	Date	Action	Rating	Price target	Hit rate
Keefe, Bruyette & Woods	Sep 16, 2026	Maintains	Market Perform	$48.00 → $50.00	75%
Piper Sandler	Jul 30, 2026	Maintains	Neutral	$45.50 → $47.00	67%
DA Davidson	Jul 30, 2026	Maintains	Neutral	$46.00 → $48.00	78%
Piper Sandler	Apr 30, 2026	Maintains	Neutral	$44.00 → $45.50	67%
DA Davidson	Apr 29, 2026	Maintains	Neutral	$44.00	78%
Keefe, Bruyette & Woods	Apr 9, 2026	Downgrade	Outperform → Market Perform	$45.00	72%
DA Davidson	Jan 29, 2026	Maintains	Neutral	$42.00 → $44.00	78%

The case for and against

Updated Oct 16, 2026

Bull case

Trustmark is positioned to benefit from a clearer path to higher profitability, as the sale-leaseback and bond restructure are expected to add about 6% to forward EPS and roughly 10 bps to NIM while supporting a stronger earnings profile into 2027. Its 1Q26 results reinforced that view, with EPS of $0.95 versus $0.86 expected, NIM stable at 3.81%, deposits up 5.5% q/q, and loans up 6.0% LQA, showing solid operating momentum and manageable credit normalization. That combination of balance-sheet growth, buyback activity, and improved profitability, together with a move from a 0.86% ROA in early '24 to +1.2% last quarter, underpins the positive outlook.

Bear case

Trustmark is viewed negatively because its earnings momentum appears constrained by interest rate risk, lower core net interest margin, and slower balance-sheet growth, while M&A execution or overpayment could further pressure profitability. Although fee income rose to $42.4M from $41.2M and expenses were flat at $132.2M, mortgage production still declined 4.6% Q/Q to $375M, limiting the quality of that improvement. Asset quality was stable but not pristine, with NPAs rising to $104M, or 0.75% of loans plus REO, and the company remains exposed to potential deterioration in its energy book and competitive loan pricing pressure.

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.